Unbound MEDLINE

Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations. European journal of pharmacology. [Eur J Pharmacol] Journal article

 
TitleRelative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
Author(s)El-Mas MM, Mohy El-Din MM, El-Gowilly SM, Sharabi FM 
InstitutionDepartment of Pharmacology, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt. elmasm@mail.ecu.edu
SourceEur J Pharmacol 2004 Mar 8; 487(1-3):149-58.
MeSHAcetylcholine
Animals
Arginine
Biological Factors
Cyclooxygenase Inhibitors
Cyclosporine
Dose-Response Relationship, Drug
Endothelium-Dependent Relaxing Factors
Enzyme Inhibitors
In Vitro
Isoproterenol
Kidney
Male
NG-Nitroarginine Methyl Ester
Nitric Oxide
Nitric Oxide Synthase
Nitric Oxide Synthase Type III
Parasympathetic Nervous System
Phenylephrine
Potassium Channel Blockers
Prostaglandins
Rats
Rats, Wistar
Receptors, Adrenergic, beta
Renal Circulation
Research Support, Non-U.S. Gov't
Vasoconstrictor Agents
Vasodilation
Vasodilator Agents
AbstractVascular toxicity is a major adverse effect for the immunosuppressant drug cyclosporine A. The present study sought to characterize the relative roles of the endothelium-derived relaxing factors (nitric oxide, endothelium-derived hyperpolarizing factor [EDHF], and prostaglandins) in the cyclosporine-induced impairment of renovascular responsiveness to acetylcholine receptor or beta-adrenoceptor activation. Changes evoked by cyclosporine in the responses to either vasorelaxant were evaluated in phenylephrine-preconstricted isolated perfused rat kidneys in the absence and presence of N(G)-nitro-l-arginine methyl ester (l-NAME, nitric oxide synthase inhibitor), tetraethylammonium (K(+) channel blocker), or diclophenac (cyclooxygenase inhibitor). Acetylcholine (0.03-2 nmol) vasodilations were significantly inhibited by prior treatment with l-NAME, tetraethylammonium, or diclophenac, suggesting a role for nitric oxide, EDHF, and prostaglandins in acetylcholine vasodilations. Isoprenaline (0.125-4 micromol) vasodilations were inhibited by l-NAME and tetraethylammonium versus no effect for diclophenac. Cyclosporine (1-4 microM) produced a concentration-related inhibition of vasodilations relaxations produced by either vasodilator. Cyclosporine-induced inhibition of acetylcholine vasodilations was attenuated in tissues pretreated with l-NAME or tetraethylammonium but not diclophenac, implicating nitric oxide and EDHF in cyclosporine-acetylcholine interaction. On the other hand, the inhibition of isoprenaline vasodilations by cyclosporine was virtually abolished by l-NAME. In cyclosporine-treated kidneys, exposure to l-arginine, the substrate of nitric oxide synthesis, fully restored isoprenaline vasodilations to control levels and significantly increased acetylcholine vasodilations. It is concluded that the identity and relative contributions of endothelial factors to renal vasodilatory responses as well as to the inhibition of these responses by cyclosporine largely depend on the vasodilator stimulus.
Languageeng
Pub Type(s)Journal Article
PubMed ID15033387
  
Advertise on this site.